0

Global Follicular Lymphoma Therapeutics Market 2018-2022

  • Published: Oct 2018
  • Pages: 106
  • SKU: IRTNTR23892
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global follicular lymphoma therapeutics market is predicted to reach a size of over USD 2.1 billion by 2022, helped by the increasing number of patient programs creating awareness about treatment of lymphoma. Wondering how to make the most of this booming follicular lymphoma therapeutics industry? Technavio’s extensive industry research report offers detailed insights that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global follicular lymphoma therapeutics market. It also examines the competitive landscape and some key companies that include Bayer, Biogen, and F. Hoffmann-La Roche.

Gain compelling insights from Technavio’s market research report. Check out the latest facts about the follicular lymphoma treatment industry

The global follicular lymphoma therapeutics market is expected to grow at a CAGR of almost 8% during the forecast period

Follicular lymphoma therapeutics industry growth is expected to accelerate massively over the next five years as top pharmaceutical companies are offering patient support programs to increase awareness about the treatment and range of cost. The Americas will drive almost 43% of the growth for the global follicular lymphoma therapeutics market, while EMEA and APAC are also predicted to make valuable contributions to the incremental growth during the forecast period. Continuous research is being conducted to develop advanced technology for the diagnosis of follicular lymphoma to provide accurate results, which is expected to fuel the demand for follicular lymphoma treatment. Technavio’s follicular lymphoma therapeutics industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Increasing government initiatives is driving the market growth

The global follicular lymphoma therapeutics market is likely to be driven by a rise in government-funded initiatives such as Cancer Breakthroughs 2020 in the US. The number of pipeline molecules being developed for follicular lymphoma treatment is rising significantly and there are multiple promising therapeutic agents for lymphoma treatment in the pipeline, which is expected to drive the demand for follicular lymphoma therapeutics across the globe. Also, the approval of new therapeutic agents broadens the available options for follicular lymphoma treatment will significantly contribute to the growth of the follicular lymphoma therapeutics industry over the next few years.

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial

 

Bayer, Biogen, and F. Hoffmann-La Roche are among the leading vendors in the follicular lymphoma therapeutics market

Most of the established companies in the follicular lymphoma therapeutics market are focused on engaging in strategic alliances to strengthen their market positions to gain a competitive advantage. At the end of 2017, biologicals dominated the global follicular lymphoma therapeutics market by product type with a share of over 56%, followed by small molecules. Many international and regional vendors are vying for their share of the market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • Bayer
  • Biogen
  • F. Hoffmann-La Roche
  • Gilead
  • Merck

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch

 

Read More Read Less

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE LANDSCAPE

PART 08: MARKET SEGMENTATION BY MOLECULE TYPE

  • Segmentation by molecule type
  • Comparison by molecule type
  • Biologicals – Market size and forecast 2017-2022
  • Small molecules – Market size and forecast 2017-2022

Market opportunity by molecule type

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity

PART 10: CUSTOMER LANDSCAPE

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Increasing patient support programs
  • Strategic alliances
  • Advanced technologies

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR LANDSCAPE

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • Biogen
  • F. Hoffmann-La Roche
  • Gilead
  • Merck

PART 16: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>